Wall Street
Price Targets

52Q Price Targets Summary
Aegirbio AB

There are no price targets for 52Q.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Aegirbio AB Competitors:
Price Targets
PYC
PYC Therapeutics Ltd
177% Upside
ANAB
AnaptysBio Inc
66% Upside
2487
Cutia Therapeutics
8% Downside
ALCLS
Cellectis SA
172% Upside
BONEX
Bonesupport Holding AB
27% Upside
ASMB
Assembly Biosciences Inc
76% Upside
DBV
DBV Technologies SA
122% Upside
145020
Hugel Inc
38% Upside

Revenue
Forecast

Revenue Estimate
Aegirbio AB

Revenue forecast
is not available for
Aegirbio AB

Operating Income
Forecast

Operating Income Estimate
Aegirbio AB

Operating Income forecast
is not available for
Aegirbio AB

Net Income
Forecast

Net Income Estimate
Aegirbio AB

Net Income forecast
is not available for
Aegirbio AB
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 52Q's stock price target?
Not Available

52Q doesn't have any price targets made by Wall Street professionals.

Back to Top